RulePep combines competitive predictive performance with additive logit reconstruction, rule-level evidence reporting, and predicate-suppression auditing, providing a transparent sequence-based framework for peptide candidate prioritization.
Abstract
Peptides are increasingly explored as therapeutic candidates, delivery vectors, and functional biomolecules, but experimental screening of peptide activity and safety remains costly because the sequence space is vast and small sequence changes can alter functionality. Computational peptide classification can therefore help prioritize candidates. However, many protein-language-model-based classifiers achieve strong performance using opaque prediction heads, making it difficult to determine which learned evidence supports or opposes a prediction. We present RulePep, an ESM-2-guided neural-symbolic classifier for peptide-function prediction. RulePep maps frozen ESM-2 sequence representation to learned latent predicates, polarity-constrained differentiable rules, and an additive symbolic logit whose components can be inspected at the case level. We evaluate RulePep on three biologically distinct peptide classification tasks: blood-brain barrier penetration, hemolytic potency, and anticancer activity. On the BBPpredict, HemoPI3, and AntiCP 2.0 alternate benchmark datasets, RulePep achieved AUROC/MCC values of 0.8869/0.6850, 0.9155/0.6820, and 0.9765/0.8633, respectively. Ablation experiments supported the contributions of multi-layer representation pooling, rule polarity, mined-rule initialization, symbolic capacity, and rule-derived aggregation. RulePep combines competitive predictive performance with additive logit reconstruction, rule-level evidence reporting, and predicate-suppression auditing, providing a transparent sequence-based framework for peptide candidate prioritization.
Overall, DrugPLMFormer provides a reproducible, leakage-aware framework for retrospective sequence-based druggability screening and target prioritization, while prospective validation and experimental confirmation remain necessary before operational deployment.
Z. Kafi, Khosro Rezaee, Hossein Eslami· Journal of King Saud Univers...· 0 citations
It is shown that single-sequence PLMs can perform in-context peptide learning without gradient updates, task-specific retraining, or architectural modification, and MPEP conditioning is established as a lightweight strategy for low-data peptide classification.
Joshua Almonte, M. Vu, Andrew Ahn et al.· bioRxiv· 0 citations
iBitter-HF is proposed, a hybrid feature embedding method that integrates seven classes of hand-crafted descriptors with Unified Representation (UniRep) features that supports iBitter-HF as a computational aid for sequence-level bitter peptide screening and debittering-oriented design of protein hydrolysates.
Feng Yan, Shi-Cheng Xiang, Yi Tang et al.· Foods· 0 citations
MolPACL is proposed, a prompt-augmentation-based supervised contrastive learning framework that incorporates high-level chemical semantics while preserving molecular identity, and achieves strong performance on both classification and regression tasks while reducing training cost.
Ali Forooghi, Luis Rueda, A. Ngom· IEEE transactions on computa...· 0 citations
Binary protein classification supports diverse tasks in computational biology, including pathway-membership inference and sequence-based candidate prioritization. Protein language models generate information-rich residue-level representations, but downstream classifiers commonly compress them using fixed pooling operat...
Jian-Yu Ren, Hanli Jiang, Puchangxin Li et al.· bioRxiv· 0 citations
An unsupervised machine-learning framework that leverages hybrid high-dimensional peptide representations to discover high-performance AFPT families without requiring 3D structures or large labeled data sets is presented and demonstrates how unsupervised hybrid-feature learning can reveal actionable biophysical design...
Nazmul Shuzan, Jialun Wei, Jie Zheng· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.